Open- and Closed-Loop Multiobjective Optimal Strategies for HIV Therapy Using NSGA-II

In this paper, multiobjective open- and closed-loop optimal treatment strategies for HIV/AIDS are presented. It is assumed that highly active antiretroviral therapy is available for treatment of HIV infection. Amount of drug usage and the quality of treatment are defined as two objectives of a biobjective optimization problem, and Nondominated Sorting Genetic Algorithm II is used to solve this problem. Open- and closed-loop control strategies are used to produce optimal control inputs, and the Pareto frontiers obtained from these two strategies are compared. Pareto frontier, resulted from the optimization process, suggests a set of treatment strategies, which all are optimal from a perspective, and can be used in different medical and economic conditions. Robustness of closed-loop system in the presence of measurement noises is analyzed, assuming various levels of noise.

[1]  Ryan Zurakowski,et al.  A model predictive control based scheduling method for HIV therapy. , 2006, Journal of theoretical biology.

[2]  Martin A Nowak,et al.  Mathematical models of HIV pathogenesis and treatment. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[3]  M. Nowak,et al.  Specific therapy regimes could lead to long-term immunological control of HIV. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Carlos E. D'Attellis,et al.  A closed-loop approach to antiretroviral therapies for HIV infection , 2009, Biomed. Signal Process. Control..

[5]  Chung Choo Chung,et al.  Optimized structured treatment interruption for HIV therapy and its performance analysis on controllability , 2006, 2004 43rd IEEE Conference on Decision and Control (CDC) (IEEE Cat. No.04CH37601).

[6]  Alessandro Astolfi,et al.  Activation of Immune Response in Disease Dynamics via Controlled Drug Scheduling , 2009, IEEE Transactions on Automation Science and Engineering.

[7]  Gareth Witten,et al.  Stability analysis of a model for HIV infection with RTI and three intracellular delays , 2009, Biosyst..

[8]  Cuifang Lv,et al.  Stability analysis of delay differential equation models of HIV-1 therapy for fighting a virus with another virus , 2009 .

[9]  Gabriele Pannocchia,et al.  A Model Predictive Control Strategy Toward Optimal Structured Treatment Interruptions in Anti-HIV Therapy , 2010, IEEE Transactions on Biomedical Engineering.

[10]  Alan S. Perelson,et al.  Mathematical Analysis of HIV-1 Dynamics in Vivo , 1999, SIAM Rev..

[11]  Xiaohua Xia,et al.  When to initiate HIV therapy: a control theoretic approach , 2003, IEEE Transactions on Biomedical Engineering.

[12]  M. Nowak,et al.  Virus dynamics: Mathematical principles of immunology and virology , 2001 .

[13]  Chung Choo Chung,et al.  Optimal Scheduling of Drug Treatment for HIV Infection : Continuous Dose Control and Receding Horizon Control , 2003 .

[14]  Kalyanmoy Deb,et al.  MULTI-OBJECTIVE FUNCTION OPTIMIZATION USING NON-DOMINATED SORTING GENETIC ALGORITHMS , 1994 .

[15]  Kalyanmoy Deb,et al.  Muiltiobjective Optimization Using Nondominated Sorting in Genetic Algorithms , 1994, Evolutionary Computation.

[16]  Matteo Bianchi,et al.  Modelling and control of HIV dynamics , 2008, Comput. Methods Programs Biomed..

[17]  Kalyanmoy Deb,et al.  A fast and elitist multiobjective genetic algorithm: NSGA-II , 2002, IEEE Trans. Evol. Comput..

[18]  I. Craig,et al.  Can HIV/AIDS be controlled? Applying control engineering concepts outside traditional fields , 2005, IEEE Control Systems.

[19]  B. Adams,et al.  HIV dynamics: Modeling, data analysis, and optimal treatment protocols , 2005 .